22.418 articles found

Effective treatment of an elderly patient with Gaucher's disease and Parkinsonism: a case report of 24 months' oral substrate reduction therapy with miglustat.

Hughes DA, Ginsberg L, Baker R, Goodwin S, Milligan A, Richfield L, Mehta AB.

Parkinsonism Relat Disord · 2006-10-16

DOI: 10.1016/j.parkreldis.2006.07.010PMID: 17049454

Are heat shock proteins therapeutic target for Parkinson's disease?

Luo GR, Chen S, Le WD.

Int J Biol Sci · 2006-10-15

DOI: 10.7150/ijbs.3.20PMID: 17200688

Rotigotine treatment partially protects from MPTP toxicity in a progressive macaque model of Parkinson's disease.

Scheller D, Chan P, Li Q, Wu T, Zhang R, Guan L, Ravenscroft P, Guigoni C, Crossman AR, Hill M, Bezard E.

Exp Neurol · 2006-10-12

DOI: 10.1016/j.expneurol.2006.08.026PMID: 17045989

Transdermal therapeutic system

GARGIULO PAUL M, LANE ROGER MICHAEL, PLATT BEATRIX, THEOBALD FRANK, WALL BETTINA.

· 2006-10-10

METHODS OF USING AND COMPOSITIONS COMPRISING SELECTIVE CYTOKINE INHIBITORY DRUGS FOR THE TREATMENT AND MANAGEMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM

ZELDIS JEROME B, SCHAFER PETER H.

· 2006-10-04

Cardiovascular responses to combined treatment with selective monoamine oxidase type B inhibitors and L-DOPA in the rat.

Finberg JP, Gross A, Bar-Am O, Friedman R, Loboda Y, Youdim MB.

Br J Pharmacol · 2006-10-03

DOI: 10.1038/sj.bjp.0706908PMID: 17016505

Peripheral inflammation and neuroprotection: systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's disease.

Armentero MT, Levandis G, Nappi G, Bazzini E, Blandini F.

Neurobiol Dis · 2006-10-03

DOI: 10.1016/j.nbd.2006.08.016PMID: 17023164

NEW PYRIMIDINE DERIVATIVES AND THEIR USE IN THERAPY AS WELL AS THE USE OF PYRIMIDINE DERIVATIVES IN THE MANUFACTURE OF A MEDICAMENT FOR PREVENTION AND/OR TREATMENT OF ALZHEIMER¿S DISEASE

ANDERSSON Lars, ARZEL Erwan, BERG Stefan, BURROWS Jeremy, HELLBERG Sven, HUERTA Fernando, PEDERSEN Torben, REIN Tobias, ROTTICCI Didier, STAAF Karin, TUREK Dominika.

· 2006-10-02

Treatment for Parkinson's Disease-combination high dose serotonergic synaptic reuptake inhibitor with phosphodiesterase inhibitor

HELD JERRY M.

· 2006-10-02

New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease

LARS ANDERSSON, ERWAN ARZEL, STEFAN BERG, JEREMY BURROWS, SVEN HELLBERG, FERNANDO HUERTA, TORBEN PEDERSEN, TOBIAS REIN, DIDIER ROTTICCI, KARIN STAAF, DOMINIKA TUREK.

· 2006-10-02

USE OF N-PIPERIDINE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE PATHOLOGIES

MERIZZI GIANFRANCO.

· 2006-10-02

New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease

ANDERSSON LARS, ARZEL ERWAN, BERG STEFAN, BURROWS JEREMY, HELLBERG SVEN, HUERTA FERNANDO, PEDERSEN TORBEN, REIN TOBIAS, ROTTICCI DIDIER, STAAF KARIN, TUREK DOMINIKA.

· 2006-10-02